Literature DB >> 18035245

Case of moyamoya disease in a patient with advanced acquired immunodeficiency syndrome.

Sophia R Sharfstein1, Shadab Ahmed, Mohammed Q Islam, Mamoun I Najjar, Vladimir Ratushny.   

Abstract

BACKGROUND: Moyamoya disease is an occlusion of the terminal portion of internal carotid arteries and proximal portion of middle and anterior cerebral arteries of unknown origin. Moyamoya syndrome is associated with meningitis, tuberculosis, syphilis, head trauma, head irradiation, brain tumor, von Recklinghausen's disease, tuberous sclerosis, Marfan syndrome, sickle cell anemia, arteriosclerosis, hypertension, and oral contraceptive use. To our knowledge, acquired immunodeficiency syndrome (AIDS) as a cause of moyamoya syndrome has not been reported in an adult population.
OBJECTIVE: We report a case of moyamoya syndrome in a patient with AIDS and without other conditions associated with occlusion of the circle of Willis and formation of collateral network at the base of the brain and basal ganglia.
METHODS: We present a case report.
RESULTS: A 29-year-old woman with an 8-year history of AIDS on multiple antiretroviral medications presented with recurrent tingling of the left extremities which 1 month later progressed to mild hemiparesis and dysarthria. During the next few months the patient developed progressive cognitive decline and on-and-off fluctuations in the degree of hemiparesis. Brain magnetic resonance imaging showed multiple small subcortical infarct's in both parietal lobes. Magnetic resonance angiography showed occlusion of middle cerebral arteries distal internal carotid arteries, with prominent collateral network. Cerebral angiography confirmed moyamoya pattern. Lumbar puncture showed: white blood cell count 1, red blood cell count 418, protein 56, glucose 53, negative bacterial and acid-fast bacilli smear and culture, negative VDRL test, India ink, cryptococcal antigen, cytology and negative polymerase chain reaction for cytomegalovirus, Epstein-Barr virus, varicella-zoster virus, and herpes simplex virus type 1 and 2. Electroencephalography showed diffuse background slowing.
CONCLUSIONS: We hypothesize that human immunodeficiency virus (HIV) caused central nervous system vasculitis, which eventually led to formation of moyamoya pattern. No other definite causes of central nervous system vasculitis were found in our patient. Cerebrovascular disorders should be considered in patients with HIV/AIDS with focal neurologic deficit. Moyamoya syndrome as a cause of stroke should be considered in patients with HIV/AIDS, especially as survival improves.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18035245     DOI: 10.1016/j.jstrokecerebrovasdis.2007.07.001

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  13 in total

1.  Primary central nervous system vasculitis and moyamoya disease: similarities and differences.

Authors:  Markus Kraemer; Peter Berlit
Journal:  J Neurol       Date:  2010-05       Impact factor: 4.849

Review 2.  Postpneumococcal Moyamoya syndrome case report and review of the postinfective cases.

Authors:  Federica Pinardi; Andrea Stracciari; Luca Spinardi; Maria Guarino
Journal:  BMJ Case Rep       Date:  2013-02-06

3.  Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.

Authors:  Nadeem I Khan; Ali A Saherwala; Mo Chen; Sepand Salehian; Hisham Salahuddin; Babu G Welch; Marco C Pinho; Ty Shang
Journal:  Cerebrovasc Dis Extra       Date:  2019-12-12

4.  Moyamoya syndrome in a known case of pulmonary tuberculosis.

Authors:  Fahmi Yousef Khan; Hussain Kamal; Rania Musa; Ahmed Hayati
Journal:  J Neurosci Rural Pract       Date:  2010-07

5.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

Review 6.  Research Progress of Moyamoya Disease in Children.

Authors:  Jianmin Piao; Wei Wu; Zhongxi Yang; Jinlu Yu
Journal:  Int J Med Sci       Date:  2015-07-03       Impact factor: 3.738

7.  Dystonia, myoclonus, and encephalopathy in a single patient: A rare association of moyamoya.

Authors:  Ujjawal Roy; Urmila Das; Ajay Panwar; Prabhat Kumar Lal
Journal:  Ann Afr Med       Date:  2016 Oct-Dec

Review 8.  Notch signaling in cerebrovascular diseases (Review).

Authors:  Zhiyou Cai; Bin Zhao; Yanqing Deng; Shouqin Shangguan; Faming Zhou; Wenqing Zhou; Xiaoli Li; Yanfeng Li; Guanghui Chen
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

Review 9.  Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.

Authors:  Takeshi Mikami; Hime Suzuki; Katsuya Komatsu; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-07-06       Impact factor: 1.742

Review 10.  HIV infection and stroke: current perspectives and future directions.

Authors:  Laura A Benjamin; Alan Bryer; Hedley C A Emsley; Saye Khoo; Tom Solomon; Myles D Connor
Journal:  Lancet Neurol       Date:  2012-10       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.